Search

You searched for "visual"

2341 results found
Ophthalmology journal front cover image.

Low-dose bimatoprost/timolol gel: a new fixed-combination option

3 February 2026 | | EYE - Glaucoma
This phase III international randomised trial evaluated the efficacy and safety of a new low concentration bimatoprost/timolol eye gel (bimatoprost 0.01%/timolol 0.1%). It was compared with the conventional higher-strength fixed combination eye drops (bimatoprost 0.03%/timolol 0.5%) in patients with open-angle...

Good news: new study links moderate wine consumption to lower risk of cataract surgery

31 March 2021
An observational study published today in Ophthalmology (the journal of the American Academy of Ophthalmology) indicates that low to moderate alcohol consumption is associated with a lower risk of requiring surgery for cataracts, although the nature of the study means it does not definitively prove a direct causal effect.

Artists Unite to showcase experiences of sight loss in new collection

1 June 2022 |
The exhibition will open on 10 June as part of the Wandsworth Arts Fringe in London.

WHO SPECS 2030: a global initiative to strengthen refractive error services

3 June 2024 | | EYE - General
Globally, it is estimated that only around one-third of people with vision impairment due to refractive error have received access to a quality pair of spectacles [1]. In recognition that uncorrected refractive error is the leading cause of vision impairment...

Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?

3 June 2021 | | EYE - Vitreo-Retinal
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...

Collaborating across the Caribbean to tackle diabetic retinopathy

1 December 2017 | | EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme has been running since 2004, with a focus on improving the quality and quantity of eye care training in low-income countries [1]. In 2014, the Diabetic Retinopathy Network (DR-NET) was established [2]. This is a...

Urban Changes and Rural Struggles for Ophthalmology in China

1 December 2013 |
China is by far the most populated country in the world, with over 1.3 billion inhabitants. It is also the country with the highest number of blind and visually impaired people. As a developing country, half of China’s population lives...

White dot syndromes

1 September 2015 | | EYE - Vitreo-Retinal
It is fair to say that trainees and consultants who are not medical retina specialists are a bit scared of the so called retinal ‘white dot syndromes’. It is easy to understand why this is the case, as almost every...

A career in uveitis

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

The College of Optometrists announces new research scholarships, grants and bursaries are open for applications

7 October 2025 | awards, funding, grants, opportunities, optometry
The College of Optometrists has announced its programme of financial support for undergraduate students, postgraduate students and members engaging in research projects in the 2025-2026 academic year is open for applications. The College has a long history of providing financial...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...